Bristol Finds Itself On The Other Side Of A Patent Suit
This article was originally published in The Pink Sheet Daily
Executive Summary
ZymoGenetics alleges Orencia infringes patents related to polypeptide fusion technology.
You may also be interested in...
Plavix Hearing Scheduled For Aug. 18 After Sanofi/Bristol File Preliminary Injunction
Apotex launch of generic clopidogrel is the “largest ‘at-risk’ infringing launch of all time,” Sanofi/Bristol court filing claims.
Apotex Launches Generic Plavix
Bristol-Myers Squibb, Sanofi-Aventis may seek preliminary injunction against Apotex.
Future BIO Global Efforts Include International Relations, Greenwood Says
HAMBURG, Germany - Due to the increasingly global nature of biotechnology, the Biotechnology Industry Organization's board of directors will meet next month to discuss a proposal to expand its global reach and potentially create a department of international relations, BIO President Jim Greenwood said Nov. 13